Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
Le dernier exercice comptable publié pour cette entreprise remonte à 2022. Les données ci-dessous peuvent ne plus refléter sa situation actuelle.
ARTEMIS II : revenue, balance sheet and financial ratios
ARTEMIS II is a French company
founded 6 years ago,
specialized in the sector Activité des médecins généralistes.
Based in SALLAUMINES (62430),
this company of category PME
shows in 2022 a revenue of 994 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-08-08
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
Synthèse
Santé financière :
Fragile
Signal structurel : exploitation déficitaire (EBE négatif).
In summary, ARTEMIS II is currently loss-making, which weighs on its accounts. Its financial structure is fragile, with debt above sector norms — a point to monitor. Point of attention: short-term liquidity is tight.
Revenue and income statement
In 2022, ARTEMIS II achieves revenue of 994 k€. After deducting consumption (26 k€), gross margin stands at 968 k€, i.e. a rate of 97%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -78 k€, representing -7.8% of revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -87 k€ (-8.7% of revenue), which will impact equity.
Revenue (2022)
?
993 910 €
Gross margin (2022)
?
968 113 €
EBITDA (2022)
?
-77 722 €
Net income (2022)
?
-86 725 €
EBITDA margin (2022)
?
-7.8%
Loading income statement...
The detailed income statement is not available for this company (simplified accounts or confidential data).
Assets
Loading data...
Assets balance sheet data not available for this company
Liabilities
Loading data...
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1891%. This ratio is less favorable than the sector median (22.1%) and warrants attention. Financial autonomy (= Equity / Total assets x 100) reaches 4%. This ratio is less favorable than the sector median (62.7%) and warrants attention. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 19.8 years of cash flow to repay all financial debt. This ratio is less favorable than the sector median (0.6 years) and warrants attention. Cash flow represents 2.3% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This ratio is less favorable than the sector median (10.8%) and warrants attention.
Debt ratio (2022)
?
1891.09%
Financial autonomy (2022)
?
3.64%
Cash flow / Revenue (2022)
?
2.34%
Repayment capacity (2022)
?
19.8
Asset age ratio (2022)
?
67.7%
| Indicator |
2021 |
2022 |
| Debt ratio |
490.912 |
1891.09 |
| Financial autonomy |
12.936 |
3.637 |
| Repayment capacity |
None |
19.799 |
| Cash flow / Revenue |
None% |
2.338% |
Sector positioning
Q1: 4.07%
Med: 22.14%
Q3: 73.49%
Watch
+18 pts over 2 years
In 2022, the debt ratio of ARTEMIS II (1891.1%) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Q1: 36.82%
Med: 62.66%
Q3: 81.22%
Watch
-7 pts over 2 years
In 2022, the financial autonomy of ARTEMIS II (3.6%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Q1: 0.01 years
Med: 0.61 years
Q3: 2.28 years
Watch
In 2022, the repayment capacity of ARTEMIS II (19.80) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 0.43. Alert: short-term debt exceeds current assets. Risk of payment difficulties without cash reinforcement.
Liquidity ratio (2022)
?
0.43
Interest coverage (2022)
?
-13.18
| Indicator |
2021 |
2022 |
| Liquidity ratio |
1.30179 |
0.42638 |
| Interest coverage |
None |
-13.178 |
Sector positioning
Q1: 1.68
Med: 3.37
Q3: 7.05
Watch
-12 pts over 2 years
In 2022, the liquidity ratio of ARTEMIS II (0.43) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Q1: 0.0x
Med: 0.27x
Q3: 1.44x
Watch
In 2022, the interest coverage of ARTEMIS II (-13.2x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 12 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 61 days. Excellent situation: suppliers finance 49 days of the operating cycle (retail model). WCR is negative (-12 days): operations structurally generate cash.
Operating WCR (2022)
?
-31 785 €
Customer credit (2022)
?
12 j
Supplier credit (2022)
?
61 j
Inventory turnover (2022)
?
0 j
WCR in days of revenue (2022)
?
-12 j
| Indicator |
2021 |
2022 |
| Operating WCR |
0 € |
-31 785 € |
| Inventory turnover (days) |
0 |
0 |
| Customer payment term (days) |
0 |
12 |
| Supplier payment term (days) |
0 |
61 |
Positioning of ARTEMIS II in its sector
Valuation estimate
Based on 274 transactions of similar company sales
(all years),
the value of ARTEMIS II is estimated at
424 139 €
(range 156 372€ - 709 686€).
The price/revenue ratio is 0.43x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
424 139 €
Range: 156 372€ - 709 686€
Section all-time
Aggregated at NAF section level
Valuation method used
Revenue Multiple
993 910 €
×
0.43x
=
424 140 €
Range: 156 372€ - 709 687€
Only this financial indicator is available for this company.
How is this estimate calculated?
This estimate is based on the analysis of 274 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
- EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
- Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
- Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Top companies in Activité des médecins généralistes
Largest companies by revenue in the sector Activité des médecins généralistes:
Frequently asked questions about ARTEMIS II
What is the revenue of ARTEMIS II ?
The revenue of ARTEMIS II in 2022 is 994 k€.
Is ARTEMIS II profitable?
ARTEMIS II recorded a net loss in 2022.
Where is the headquarters of ARTEMIS II ?
The headquarters of ARTEMIS II is located in SALLAUMINES (62430), in the department Pas-de-Calais.
Where to find the tax return of ARTEMIS II ?
The tax return of ARTEMIS II is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does ARTEMIS II operate?
ARTEMIS II operates in the sector Activité des médecins généralistes (NAF code 86.21Z). See the 'Sector positioning' section above to compare the company with its competitors.